Announcement

 

Stephen Cork and Anthony Cork of Cork Gully LLP have been appointed to act as Joint Administrators of Smart Matrix Limited (in administration) (the “Company”) on 16 December 2021. The business and affairs of the Company will now be managed by the Joint Administrators and their staff. The Joint Administrators will now take steps to realise assets of the Company for the benefit of the Company and its creditors and will issue proposals detailing how the purpose of the administration is intended to be achieved within eight weeks from the date of the administration.

In the event that you have any immediate queries in respect of the Company position, the day-to-day administration contacts are as follows:

Mark Smith
Director

Liam Jones
Executive

Cork Gully LLP
6 Snow Hill
London
EC1A 2AY

Telephone: +44 (0) 20 7268 2150
Facsimile: +44 (0) 20 7002 7788

Smart Matrix®

Next generation wound care

Smart Matrix®

Next generation wound care

About Smart Matrix®

Smart Matrix® is a ground breaking new medical device that acts as a scaffold to assist wound healing by assisting the body’s natural healing process, allowing the skin to regenerate, achieving wound closure without the need for a skin graft.

Smart Matrix Limited is the award-winning company behind the development of Smart Matrix®.

About Smart Matrix®

Smart Matrix® is a ground breaking new medical device that acts as a scaffold to assist wound healing by assisting the body’s natural healing process, allowing the skin to regenerate, achieving wound closure without the need for a skin graft.

Smart Matrix Limited is the award-winning company behind the development of Smart Matrix®.

Application

How it works

Smart Matrix® harnesses the body’s own healing processes. It acts as a scaffold to provide a framework for new blood vessels and skin cells to infiltrate a wound, critical to healthy skin regeneration and repair. Smart Matrix® is a single application device and is absorbed into the body as wound healing progresses.

Preliminary data suggest that Smart Matrix® enables wound healing without the need for a skin graft, unlike other treatments for “full thickness” or deep skin wounds.
 

Clinical uses

Smart Matrix® is primarily being developed as a clinical treatment for surgical wounds, such as in the removal of skin cancer tumours. Other potential uses include the treatment of chronic wounds, severe burns, trauma injuries, military wounds and ulcers.

A clinical trial is currently being prepared, to be carried out in 2018.

Our team

An executive management team and board, with significant experience in bringing medical devices to the market, is in place to advance the development of Smart Matrix®.

Our team

An executive management team and board, with significant experience in bringing medical devices to the market, is in place to advance the development of Smart Matrix®.

Francis Gugen, FCA (UK) FEI (UK) - Executive Chairman

Francis originally conceived and drove the foundation of Smart Matrix Limited whilst chairman of RAFT (The Restoration of Appearance and Function Trust), where the original research into Smart Matrix® was carried out.

Dr Lilian Hook, BA, MA (Cantab), MSc (UCL), PhD (Edinburgh) - Executive Director

Lilian oversees Smart Matrix® product research and development and joined the Smart Matrix Limited team part-time in 2014 and permanently in August 2017.

Jeremy Curnock Cook, BA Hons (Trinity Dublin), MA (Trinity Dublin) - Non-Executive Director

Jeremy has fund management expertise, most recently creating new funds of A$100m, and A$50m in size, targeting the healthcare sector.

William (Bill) Allan, BDS (Edinburgh), MBA (Cape Town), AMP (Insead) - Non-Executive Director

Bill is an internationally experienced medical devices executive and entrepreneur who has held a number of global leadership positions with large Multinational medical device companies.

Contact us

14 + 12 =